Parkinson's disease, a progressive and degenerative brain condition, affects more than 1 percent of individuals over the age of 60 worldwide, leading to symptoms such as slow movements, muscle tremors, stiffness, and difficulty walking. Traditional treatments focus primarily on managing
In the dynamic world of modern medicine, expectations run high for treatments that are not only effective but also minimize risks. Yet, conventional cancer therapies often walk a fine line between disease eradication and severe side effects. What if there was a way to tailor treatments to each
Chinese contract research organization GemPharmatech has expanded its presence in the United States with a new facility in San Diego, announced on April 17. The facility is designed for laboratories and housing genetically engineered mouse models, aimed at enhancing their capabilities in offering
With over 300 million people globally suffering from chronic hepatitis B, the disease presents a monumental challenge in the realm of public health. Traditional treatments have mainly focused on suppressing the virus rather than providing a cure, demanding lifelong therapy for many patients.
Allogene Therapeutics, a clinical-stage biotechnology company based in South San Francisco, has achieved a groundbreaking milestone. Their investigational product, ALLO-329, has received three Fast Track Designations (FTDs) from the FDA, marking a significant advancement in the treatment of
Metastatic breast cancer remains one of the most challenging forms of cancer to treat, with only about one-third of patients surviving beyond five years post-diagnosis. Traditional treatments such as chemotherapy, radiation, and surgery have shown limited effectiveness, often accompanied by
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66
